Kang JK et al. – This trial demonstrated that stereotactic body radiation therapy (SBRT) after incomplete transarterial chemoembolization (TACE) for inoperable hepatocellular carcinoma (HCC) achieves promising rates of response and local control. On the basis of these study results, a modified, multi–institutional, phase 2 trial to reduce gastrointestinal toxicity is recommended. [more...]
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close